CTX112

Live / Registered — Registered (as of 10 Feb 2026)

What this means for you

Registered since 10 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97371562
Registration number
8137640
Mark type
Stylized text
Filed
20 Apr 2022
Published for opposition
23 Apr 2024
Registered
10 Feb 2026
Attorney of record
Tiffany D. Gehrke

Goods and services

  • Class 005 — Pharmaceuticals: Cells for medical or clinical use in the field of CAR T cell therapy for the treatment of cancer and autoimmune diseases; pharmaceutical and biopharmaceutical agents for the treatment of cancer in the field of CAR T cell therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer in the field of CAR T cell therapy
  • Class 042 — Scientific and technological services: Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of CAR T cell therapy for the treatment of cancer and autoimmune diseases; gene editing, namely, pharmaceutical research and development in the field of CAR T cell therapy for the treatment of cancer and autoimmune diseases

Owner

Prosecution history

  • 10 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 10 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
  • 22 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 22 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 05 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 05 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 05 Jan 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
  • 02 Jan 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
  • 02 Jan 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
  • 09 Oct 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
  • 09 Oct 2025 — FINAL REFUSAL E-MAILED
  • 09 Oct 2025 — SU - FINAL REFUSAL - WRITTEN
  • 16 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 16 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 10 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED

View this trademark record on Marksy